Astec Lifesciences Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Promoters have been increasing their shareholding - up 5.2pp over 2 years
- Working capital cycle has improved - days down from -29 to -47
CONS
- Company is loss-making at the operating / net level
- Operating cash flow has been negative in recent years
- Company has a low return on equity of -27.6% over last 3 years
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of -7.6%
- Interest coverage is weak at -1.3x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| UPL | 577.00 | 24.11 | 48708.57 | 1.04 | -73.00 | 58.52 | 10181.00 | 10.47 | 12.00 | 13.43 |
| PIIND | 2396.05 | 31.20 | 36352.42 | 0.63 | 244.20 | -38.95 | 1702.30 | -10.43 | 16.00 | 21.69 |
| SUMICHEM | 481.50 | 41.48 | 24033.87 | 0.27 | 214.51 | 20.45 | 1063.35 | 0.62 | 23.39 | 21.94 |
| BAYERCROP | 3948.35 | 320.25 | 17744.71 | 3.80 | 321.60 | 15.39 | 1835.00 | -4.16 | 30.08 | 20.03 |
| SHARDACROP | 783.10 | 11.28 | 7065.17 | 1.92 | 88.02 | -38.36 | 1073.77 | 9.03 | 31.10 | 17.32 |
| DHANUKA | 977.80 | 14.68 | 4358.87 | 0.20 | 75.50 | 27.94 | 442.02 | 20.01 | 24.44 | 24.83 |
| RALLIS | 203.90 | 24.15 | 3965.22 | 1.47 | -14.15 | -274.26 | 507.54 | 7.70 | 13.23 | -0.56 |
| NACLIND | 164.35 | 311.22 | 3849.79 | 0.00 | 20.84 | 59.82 | 383.33 | -14.50 | 6.20 | 10.80 |
| BHAGCHEM | 263.40 | 124.10 | 3415.48 | 0.06 | 133.29 | 3249.84 | 1950.19 | 1475.55 | 4.55 | 15.65 |
| GSPCROP | 491.20 | 23.34 | 2285.00 | 0.20 | 263.94 | 1111.46 | 3859.95 | 1153.27 | 18.46 | 11.02 |
| BHARATRAS | 1170.30 | 13.57 | 1945.16 | 0.04 | 372.30 | 838.73 | 3381.60 | 796.03 | 16.63 | 15.19 |
| ASTEC | 762.70 | 0.00 | 1699.51 | 0.00 | -18.71 | 43.36 | 83.56 | -8.25 | -5.71 | -0.80 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 143 | 111 | 51 | 154 | 69 | 99 | 94 | 120 | 91 | 74 | 125 | 159 | 84 | |
| 140 | 114 | 69 | 141 | 116 | 118 | 100 | 114 | 102 | 80 | 121 | 149 | 103 | |
| Operating Profit | 3 | -3 | -18 | 13 | -46 | -20 | -6 | 6 | -11 | -7 | 4 | 9 | -19 |
| OPM % | 2.20% | -3.09% | -36.09% | 8.27% | -66.67% | -20.02% | -6.12% | 4.63% | -12.07% | -9.06% | 3.20% | 5.77% | -23.32% |
| 2 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 0 | 1 | -1 | 3 | 1 | |
| Interest | 6 | 6 | 6 | 7 | 7 | 9 | 10 | 10 | 11 | 8 | 7 | 8 | 8 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 11 | 11 | 12 | 12 | 10 | 11 | 12 | 11 |
| Profit before Tax | -11 | -18 | -32 | -1 | -62 | -39 | -25 | -16 | -33 | -24 | -16 | -8 | -19 |
| Tax % | 25.66% | 23.75% | 24.50% | -3.12% | 35.56% | -0.00% | -60.44% | -2.61% | -0.00% | -0.00% | -0.00% | 2.02% | 0.22% |
| Net Profit | -8 | -13 | -24 | -1 | -40 | -39 | -40 | -16 | -33 | -24 | -16 | -8 | -19 |
| -4.19 | -6.86 | -12.42 | -0.50 | -20.26 | -19.67 | -20.60 | -8.21 | -16.86 | -11.39 | -7.06 | -3.49 | -8.41 |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 313 | 371 | 431 | 522 | 555 | 677 | 628 | 458 | 381 | 448 | 441 | |
| 250 | 302 | 354 | 437 | 443 | 522 | 552 | 464 | 447 | 453 | 454 | |
| Operating Profit | 62 | 69 | 76 | 85 | 111 | 154 | 76 | -6 | -66 | -5 | -13 |
| OPM % | 19.92% | 18.54% | 17.73% | 16.32% | 20.08% | 22.77% | 12.14% | -1.29% | -17.36% | -1.01% | -2.95% |
| -8 | 12 | 11 | 12 | 8 | 10 | 13 | 6 | 6 | 3 | 3 | |
| Interest | 12 | 11 | 12 | 13 | 5 | 9 | 21 | 25 | 37 | 35 | 31 |
| Depreciation | 14 | 15 | 19 | 23 | 26 | 34 | 34 | 36 | 44 | 45 | 45 |
| Profit before Tax | 29 | 56 | 56 | 61 | 89 | 121 | 35 | -62 | -141 | -81 | -67 |
| Tax % | 33.30% | 37.19% | 36.04% | 22.53% | 27.04% | 25.80% | 26.77% | 24.06% | 4.47% | 0.20% | 0.30% |
| Net Profit | 19 | 35 | 36 | 47 | 65 | 90 | 26 | -47 | -135 | -81 | -67 |
| EPS | 9.77 | 17.88 | 18.23 | 24.25 | 33.02 | 45.83 | 13.02 | -23.96 | -68.74 | -36.36 | — |
| Dividend Payout % | 15.33% | 8.38% | 8.22% | 6.18% | 4.54% | 3.27% | 11.52% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 7%
- 5 Years:
- -4%
- 3 Years:
- -11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 6%
- 5 Years:
- -12%
- 3 Years:
- -20%
- 1 Year:
- -16%
RETURN ON EQUITY
- 10 Years:
- 5%
- 5 Years:
- -10%
- 3 Years:
- -28%
- Last Year:
- -26%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 |
| 118 | 149 | 182 | 226 | 289 | 376 | 399 | 349 | 214 | 367 | |
| 126 | 124 | 176 | 99 | 187 | 241 | 298 | 484 | 545 | 360 | |
| Trade Payables | 57 | 100 | 64 | 203 | 129 | 190 | 177 | 89 | 82 | 88 |
| 13 | 20 | 20 | 24 | 53 | 99 | 86 | 33 | 26 | 104 | |
| Total Liabilities | 334 | 413 | 461 | 572 | 678 | 925 | 979 | 974 | 886 | 941 |
| 103 | 115 | 167 | 194 | 213 | 340 | 318 | 386 | 499 | 459 | |
| Capital Work in Progress | 8 | 42 | 19 | 22 | 112 | 14 | 112 | 148 | 0 | 0 |
| 66 | 78 | 93 | 121 | 106 | 187 | 295 | 196 | 160 | 138 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 169 | 147 | 248 | |
| Cash & Bank | 4 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 11 |
| 153 | 176 | 181 | 233 | 245 | 383 | 251 | 73 | 78 | 85 | |
| Total Assets | 334 | 413 | 461 | 572 | 678 | 925 | 979 | 974 | 886 | 941 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 80 | 32 | 187 | 15 | 53 | 79 | 10 | -8 | -81 | |
| Cash from Investing | -18 | -49 | -52 | -74 | -73 | -104 | -112 | -135 | -15 | -4 |
| Cash from Financing | -1 | -18 | 37 | -95 | 81 | 80 | 38 | 125 | 24 | 94 |
| 1 | -2 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 9 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-10 - Significant movement in price has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
2026-09-09 - Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.
2026-09-08 - Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
2026-08-01 - Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding 'Adoption of Annual Report 2025-26 by the Shareholders at the AGM held on 31st July, 2026.'.
2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 31, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
2026-07-31 - Astec LifeSciences Limited has informed the Exchange about General Updates
2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "ASTEC: Astec LifeSciences Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Press Release for the Quarter ended June 30, 2026".
2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding Outcome of Board Meeting held on July 31, 2026.
News
Recent coverage and analyst commentary for ASTEC
Loading news…
AI Stock Analyst
Astec Lifesciences Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account